Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 272 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Zarogoulidis, Paul  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
I
Katopodi, T., Petanidis S., Grigoriadou E., Anestakis D., Charalampidis C., Chatziprodromidou I., et al. (2024).  Immune Specific and Tumor-Dependent mRNA Vaccines for Cancer Immunotherapy: Reprogramming Clinical Translation into Tumor Editing Therapy.. Pharmaceutics. 16(4), 
Katopodi, T., Petanidis S., Anestakis D., Charalampidis C., Chatziprodromidou I., Floros G., et al. (2023).  Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery.. Pharmaceutics. 15(10), 
Zarogoulidis, K., Ziogas E., Boutsikou E., Zarogoulidis P., Darwiche K., Kontakiotis T., et al. (2013).  Immunomodifiers in combination with conventional chemotherapy in small cell lung cancer: a phase II, randomized study.. Drug Des Devel Ther. 7, 611-7.
Zarogoulidis, P., Athanasiou E., Tsiouda T., Hatzibougias D., Huang H., Bai C., et al. (2017).  Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.. Respir Med Case Rep. 22, 197-202.
Zarogoulidis, P., Huang H., Tsiouda T., Sardeli C., Trakada G., Veletza L., et al. (2017).  Immunotherapy "Shock" with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma.. Respir Med Case Rep. 22, 283-286.
Mylonaki, E., Manika K., Zarogoulidis P., Domvri K., Voutsas V., Zarogoulidis K., et al. (2012).  In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.. Mutat Res. 740(1-2), 1-5.
Kolettas, A., Grosomanidis V., Kolettas V., Zarogoulidis P., Tsakiridis K., Katsikogiannis N., et al. (2014).  Influence of apnoeic oxygenation in respiratory and circulatory system under general anaesthesia.. J Thorac Dis. 6 Suppl 1, S116-45.
Sardeli, C., Zarogoulidis P., Kosmidis C., Amaniti A., Katsaounis A., Giannakidis D., et al. (2020).  Inhaled chemotherapy adverse effects: mechanisms and protection methods.. Lung Cancer Manag. 8(4), LMT19.
Zarogoulidis, P., Darwiche K., Krauss L., Huang H., Zachariadis G. A., Katsavou A., et al. (2013).  Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients.. Future Oncol. 9(9), 1307-13.
Kosmidis, C., Sapalidis K., Zarogoulidis P., Sardeli C., Koulouris C., Giannakidis D., et al. (2019).  Inhaled Cisplatin for NSCLC: Facts and Results.. Int J Mol Sci. 20(8), 
Zarogoulidis, P., Kontakiotis T., & Zarogoulidis K. (2012).  Inhaled gene therapy in lung cancer: "as for the future, our task is not to foresee it, but to enable it".. Ther Deliv. 3(8), 919-21.
Zarogoulidis, P., Darwiche K., Hohenforst-Schmidt W., Huang H., Li Q., Freitag L., et al. (2013).  Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer.. Future Oncol. 9(8), 1171-94.
Sapalidis, K., Zarogoulidis P., Huang H., Bai C., Wen Y., Wang L., et al. (2018).  Inhaled Immunotherapy Administration for Lung Cancer; Efficient? Certainly Possible.. J Cancer. 9(6), 1121-1126.
Zarogoulidis, P., Papanas N., Kouliatsis G., Spyratos D., Zarogoulidis K., & Maltezos E. (2011).  Inhaled insulin: too soon to be forgotten?. J Aerosol Med Pulm Drug Deliv. 24(5), 213-23.
Pitsiou, G., Zarogoulidis P., Petridis D., Kioumis I., Lampaki S., Organtzis J., et al. (2014).  Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment.. Drug Des Devel Ther. 8, 1753-63.
Zarogoulidis, P., Pataka A., Terzi E., Hohenforst-Schmidt W., Machairiotis N., Huang H., et al. (2013).  Intensive care unit and lung cancer: when should we intubate?. J Thorac Dis. 5 Suppl 4, S407-12.
Kosmidis, C., Sapalidis K., Koletsa T., Kosmidou M., Efthimiadis C., Anthimidis G., et al. (2018).  Interferon-γ and Colorectal Cancer: an up-to date.. J Cancer. 9(2), 232-238.
Zarogoulidis, P., Yarmus L., Darwiche K., Walter R., Huang H., Li Z., et al. (2013).  Interleukin-6 cytokine: a multifunctional glycoprotein for cancer.. Immunome Res. 9(62), 16535.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.